Cargando…
Correction: Transcriptome profiling analysis reveals that CXCL2 is involved in anlotinib resistance in human lung cancer cells
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270796/ https://www.ncbi.nlm.nih.gov/pubmed/35804347 http://dx.doi.org/10.1186/s12920-022-01309-6 |
| _version_ | 1784744544314589184 |
|---|---|
| author | Lu, Jun Xu, Wei Qian, Jie Wang, Shuyuan Zhang, Bo Zhang, Lele Qiao, Rong Hu, Minjuan Zhao, Yiming Zhao, Xiaodong Han, Baohui |
| author_facet | Lu, Jun Xu, Wei Qian, Jie Wang, Shuyuan Zhang, Bo Zhang, Lele Qiao, Rong Hu, Minjuan Zhao, Yiming Zhao, Xiaodong Han, Baohui |
| author_sort | Lu, Jun |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9270796 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92707962022-07-10 Correction: Transcriptome profiling analysis reveals that CXCL2 is involved in anlotinib resistance in human lung cancer cells Lu, Jun Xu, Wei Qian, Jie Wang, Shuyuan Zhang, Bo Zhang, Lele Qiao, Rong Hu, Minjuan Zhao, Yiming Zhao, Xiaodong Han, Baohui BMC Med Genomics Correction BioMed Central 2022-07-08 /pmc/articles/PMC9270796/ /pubmed/35804347 http://dx.doi.org/10.1186/s12920-022-01309-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Lu, Jun Xu, Wei Qian, Jie Wang, Shuyuan Zhang, Bo Zhang, Lele Qiao, Rong Hu, Minjuan Zhao, Yiming Zhao, Xiaodong Han, Baohui Correction: Transcriptome profiling analysis reveals that CXCL2 is involved in anlotinib resistance in human lung cancer cells |
| title | Correction: Transcriptome profiling analysis reveals that CXCL2 is involved in anlotinib resistance in human lung cancer cells |
| title_full | Correction: Transcriptome profiling analysis reveals that CXCL2 is involved in anlotinib resistance in human lung cancer cells |
| title_fullStr | Correction: Transcriptome profiling analysis reveals that CXCL2 is involved in anlotinib resistance in human lung cancer cells |
| title_full_unstemmed | Correction: Transcriptome profiling analysis reveals that CXCL2 is involved in anlotinib resistance in human lung cancer cells |
| title_short | Correction: Transcriptome profiling analysis reveals that CXCL2 is involved in anlotinib resistance in human lung cancer cells |
| title_sort | correction: transcriptome profiling analysis reveals that cxcl2 is involved in anlotinib resistance in human lung cancer cells |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270796/ https://www.ncbi.nlm.nih.gov/pubmed/35804347 http://dx.doi.org/10.1186/s12920-022-01309-6 |
| work_keys_str_mv | AT lujun correctiontranscriptomeprofilinganalysisrevealsthatcxcl2isinvolvedinanlotinibresistanceinhumanlungcancercells AT xuwei correctiontranscriptomeprofilinganalysisrevealsthatcxcl2isinvolvedinanlotinibresistanceinhumanlungcancercells AT qianjie correctiontranscriptomeprofilinganalysisrevealsthatcxcl2isinvolvedinanlotinibresistanceinhumanlungcancercells AT wangshuyuan correctiontranscriptomeprofilinganalysisrevealsthatcxcl2isinvolvedinanlotinibresistanceinhumanlungcancercells AT zhangbo correctiontranscriptomeprofilinganalysisrevealsthatcxcl2isinvolvedinanlotinibresistanceinhumanlungcancercells AT zhanglele correctiontranscriptomeprofilinganalysisrevealsthatcxcl2isinvolvedinanlotinibresistanceinhumanlungcancercells AT qiaorong correctiontranscriptomeprofilinganalysisrevealsthatcxcl2isinvolvedinanlotinibresistanceinhumanlungcancercells AT huminjuan correctiontranscriptomeprofilinganalysisrevealsthatcxcl2isinvolvedinanlotinibresistanceinhumanlungcancercells AT zhaoyiming correctiontranscriptomeprofilinganalysisrevealsthatcxcl2isinvolvedinanlotinibresistanceinhumanlungcancercells AT zhaoxiaodong correctiontranscriptomeprofilinganalysisrevealsthatcxcl2isinvolvedinanlotinibresistanceinhumanlungcancercells AT hanbaohui correctiontranscriptomeprofilinganalysisrevealsthatcxcl2isinvolvedinanlotinibresistanceinhumanlungcancercells |